Viral Hepatitis C - Chiron Reports 2005 Adjusted Earnings of $1.34 Per Share, GAAP ...

Chiron Reports 2005 Adjusted Earnings of $1.34 Per Share, GAAP ...
Business Wire (press release), CA - Jan 31, 2006... of upfront payments and royalties, and a settlement with the Scottish National Blood Transfusion Service regarding certain Chiron hepatitis C (HCV) and HIV ...

Transition Therapeutics Increases Ownership Stake in Ellipsis ...
Canada NewsWire (press release), Canada - Feb 6, 2006... include regenerative therapies E1-INT(TM) and GLP1-INT(TM) for the treatment of diabetes, MS-IET for the treatment of multiple sclerosis and HCV-IET for the ...

Schering-Plough's HCV drug gets fast track
United Press International - Jan 30, 2006KENILWORTH, NJ, Jan. 30 (UPI) -- Schering-Plough said Monday the Food and Drug Administration granted fast-track status to its potential hepatitis drug. ...

FDA Grants Fast Track Designation To Oral HCV Protease Inhibitor ...
Medical News Today (press release), UK - Jan 30, 2006... oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment of chronic hepatitis C virus (HCV) infection. ...

Hepatitis C screening urged
Hindu, India - Feb 3, 2006CHENNAI: Experts have called for campaigns to promote screening for the Hepatitis C Virus (HCV), which is currently estimated to have put around 15 million ...